AMRNライブシグナル | Getagraph.comで利益を最大化

売る 107906 min ago

@ $1.160

発行日: 15 2月 2024 @ 03:12

リターン: -24.39%

前回のシグナル: 2月 14 - 00:19

前回のシグナル: 買う

リターン: -0.85 %

Live Chart Being Loaded With Signals

Commentary (30 4月 2024 @ 01:38):

Stats
本日の出来高	327 877
平均出来高	1.56M
時価総額	358.58M
EPS	$0 ( 2024-02-29 )
次の収益日	( $-0.0400 ) 2024-05-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-5.85
ATR14	$0.00200 (0.23%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-18	Cohen Paul	Buy	179 795	Stock Option (right to buy)
2024-04-18	Cohen Paul	Buy	50 287	Restricted Stock Unit
2024-04-18	Sullivan Diane E.	Buy	179 795	Stock Option (right to buy)
2024-04-18	Sullivan Diane E.	Buy	50 287	Restricted Stock Unit
2024-04-18	Sterling Louis Iii	Buy	179 795	Stock Option (right to buy)

INSIDER POWER
88.58
Last 98 transactions
Buy: 13 429 087 \| Sell: 697 874

ボリューム相関

長: -0.23 (neutral)

短: -0.97 (very strong negative)

Signal:(53.466) Neutral

Amarin Corporation PLC 相関

10 最も正の相関
ASTR	0.96
VCNX	0.958
RSLS	0.956
MNRO	0.955
CAMP	0.954
RENT	0.954
RICK	0.953
LYT	0.953
AEMD	0.952
ENTA	0.951

10 最も負の相関
PRSR	-0.961
HERA	-0.956
AGGR	-0.954
GXII	-0.952
MCAA	-0.952
CRZN	-0.949
LVRA	-0.949
LEGA	-0.949
TBSA	-0.948
XFIN	-0.947

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Amarin Corporation PLC 相関 - 通貨/商品

0.20
( neutral )

0.30
( neutral )

0.00
( neutral )

-0.78
( moderate negative )

Amarin Corporation PLC 財務諸表

Annual	2023
収益:	$308.10M
総利益:	$202.59M (65.75 %)
EPS:	$-0.150

FY	2023
収益:	$308.10M
総利益:	$202.59M (65.75 %)
EPS:	$-0.150

FY	2022
収益:	$369.19M
総利益:	$242.48M (65.68 %)
EPS:	$-0.260

FY	2021
収益:	$583.19M
総利益:	$461.86M (79.20 %)
EPS:	$0.0200

Financial Reports:

No articles found.

Amarin Corporation PLC

Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

リアルタイムの更新： Amarin Corporation PLC [AMRN]

Upcoming Earnings Alert